Loading...
Thumbnail Image
Publication

BacMam Virus Transduced Cardiomyoblasts Can Be Used for Myocardial Transplantation Using AP-PEG-A Microcapsules: Molecular Cloning, Preparation, and In Vitro Analysis

Paul, Arghya
Khan, Afshan Afsar
Shum-Tim, Dominique
Prakash, Satya
Citations
Altmetric:
Abstract
The potential of genetically modified cardiomyoblasts in treating damaged myocardium is well known. However, efficient delivery of these cells is of major concern during treatment. The limiting factors are the massive cell death that occurs soon after their intramyocardial transplantation into the beating heart. To address these problems, we generated recombinant baculoviruses (BacMam viruses) which efficiently transduced cardiomyoblast cells under optimized conditions. These genetically modified cells were then protected in a new polymeric microcapsule using poly-ethylene-glycol (PEG), alginate, and poly-L-lysine (PLL) polymers for efficient delivery. Results showed that microcapsules maintain cell viability and support cell proliferation for at least 30 days. The capsules exhibit strong immunoprotective potential and have high mechanical and osmotic stability with more than 70% intact capsules. The encased transduced cells showed a rapid transgene expression inside the capsule for at least 15 days. However, preclinical studies are needed to further explore its long-term functional benefits.
Description
Date
2010
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Publishing Corporation
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Paul, Arghya, Afshan Afsar Khan, Dominique Shum-Tim, and Satya Prakash. "BacMam Virus Transduced Cardiomyoblasts Can Be Used for Myocardial Transplantation Using AP-PEG-A Microcapsules: Molecular Cloning, Preparation, and In Vitro Analysis." Journal of Biomedicine and Biotechnology 2010 (2010): 1-12. http://dx.doi.org/10.1155/2010/858094
Embedded videos